Publications

Detailed Information

Functional Extracellular Vesicles for Regenerative Medicine

DC Field Value Language
dc.contributor.authorKim, Han Young-
dc.contributor.authorKwon, Seunglee-
dc.contributor.authorUm, Wooram-
dc.contributor.authorShin, Sol-
dc.contributor.authorKim, Chan Ho-
dc.contributor.authorPark, Jae Hyung-
dc.contributor.authorKim, Byung-Soo-
dc.date.accessioned2024-06-13T02:10:58Z-
dc.date.available2024-06-13T02:10:58Z-
dc.date.created2022-04-26-
dc.date.created2022-04-26-
dc.date.created2022-04-26-
dc.date.issued2022-09-
dc.identifier.citationSmall, Vol.18 No.36, p. 2106569-
dc.identifier.issn1613-6810-
dc.identifier.urihttps://hdl.handle.net/10371/204226-
dc.description.abstract© 2022 Wiley-VCH GmbHThe unique biological characteristics and promising clinical potential of extracellular vesicles (EVs) have galvanized EV applications for regenerative medicine. Recognized as important mediators of intercellular communication, naturally secreted EVs have the potential, as innate biotherapeutics, to promote tissue regeneration. Although EVs have emerged as novel therapeutic agents, challenges related to the clinical transition have led to further functionalization. In recent years, various engineering approaches such as preconditioning, drug loading, and surface modification have been developed to potentiate the therapeutic outcomes of EVs. Also, limitations of natural EVs have been addressed by the development of artificial EVs that offer advantages in terms of production yield and isolation methodologies. In this review, an updated overview of current techniques is provided for the functionalization of natural EVs and recent advances in artificial EVs, particularly in the scope of regenerative medicine.-
dc.language영어-
dc.publisherWiley - V C H Verlag GmbbH & Co.-
dc.titleFunctional Extracellular Vesicles for Regenerative Medicine-
dc.typeArticle-
dc.identifier.doi10.1002/smll.202106569-
dc.citation.journaltitleSmall-
dc.identifier.wosid000772218600001-
dc.identifier.scopusid2-s2.0-85126850345-
dc.citation.number36-
dc.citation.startpage2106569-
dc.citation.volume18-
dc.description.isOpenAccessN-
dc.contributor.affiliatedAuthorKim, Byung-Soo-
dc.type.docTypeReview-
dc.description.journalClass1-
dc.subject.keywordPlusMESENCHYMAL STEM-CELL-
dc.subject.keywordPlusEXOSOME-MEDIATED DELIVERY-
dc.subject.keywordPlusDRUG-DELIVERY-
dc.subject.keywordPlusSURFACE FUNCTIONALIZATION-
dc.subject.keywordPlusMYOCARDIAL-INFARCTION-
dc.subject.keywordPlusMIMETIC NANOVESICLES-
dc.subject.keywordPlusENGINEERING EXOSOMES-
dc.subject.keywordPlusHEART-FAILURE-
dc.subject.keywordPlusRNA-
dc.subject.keywordPlusANGIOGENESIS-
dc.subject.keywordAuthorexosomes-
dc.subject.keywordAuthorextracellular vesicles-
dc.subject.keywordAuthorfunctionalization-
dc.subject.keywordAuthornanovesicles-
dc.subject.keywordAuthorregenerative medicine-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Related Researcher

  • College of Engineering
  • School of Chemical and Biological Engineering
Research Area biomaterials, nanomedicine, regenerative medicine

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share